Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021			114,991,000
Beginning balance at Dec. 31, 2021	$ 121,599		$ 11	$ 323,666	$ 0	$ (202,078)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	7,557			7,557
Proceeds from option exercises (shares)			723,000
Proceeds from option exercises	131		$ 1	130
Net (loss) income	44,894					44,894
Ending balance (in shares) at Mar. 31, 2022			115,714,000
Ending balance at Mar. 31, 2022	174,181		$ 12	331,353	0	(157,184)
Beginning balance (in shares) at Dec. 31, 2021			114,991,000
Beginning balance at Dec. 31, 2021	121,599		$ 11	323,666	0	(202,078)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	39,061
Foreign currency translation	27
Ending balance (in shares) at Jun. 30, 2022			116,252,000
Ending balance at Jun. 30, 2022	175,847		$ 12	338,825	27	(163,017)
Beginning balance (in shares) at Dec. 31, 2021			114,991,000
Beginning balance at Dec. 31, 2021	$ 121,599		$ 11	323,666	0	(202,078)
Ending balance (in shares) at Dec. 31, 2022	116,432,029		116,432,000
Ending balance at Dec. 31, 2022	$ 97,386	$ (33)	$ 12	350,247	193	(253,066)	$ (33)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Beginning balance (in shares) at Mar. 31, 2022			115,714,000
Beginning balance at Mar. 31, 2022	$ 174,181		$ 12	331,353	0	(157,184)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	7,103			7,103
Proceeds from option exercises (shares)			538,000
Proceeds from option exercises	369		$ 0	369
Net (loss) income	(5,833)					(5,833)
Foreign currency translation	27				27
Ending balance (in shares) at Jun. 30, 2022			116,252,000
Ending balance at Jun. 30, 2022	$ 175,847		$ 12	338,825	27	(163,017)
Beginning balance (in shares) at Dec. 31, 2022	116,432,029		116,432,000
Beginning balance at Dec. 31, 2022	$ 97,386	(33)	$ 12	350,247	193	(253,066)	(33)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,286			5,286
Proceeds from option exercises (shares)			30,000
Proceeds from option exercises	12			12
Proceeds from issuance of stock under the employee stock purchase plan (in shares)			267,000
Proceeds from issuance of stock under the employee stock purchase plan	75			75
Net (loss) income	(24,628)					(24,628)
Foreign currency translation	13				13
Ending balance (in shares) at Mar. 31, 2023			116,729,000
Ending balance at Mar. 31, 2023	$ 78,111		$ 12	355,620	206	(277,727)
Beginning balance (in shares) at Dec. 31, 2022	116,432,029		116,432,000
Beginning balance at Dec. 31, 2022	$ 97,386	$ (33)	$ 12	350,247	193	(253,066)	$ (33)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from option exercises (shares)	82,000
Proceeds from issuance of stock under the employee stock purchase plan (in shares)			267,401
Net (loss) income	$ (44,206)
Foreign currency translation	$ 22
Ending balance (in shares) at Jun. 30, 2023	117,107,326		117,107,000
Ending balance at Jun. 30, 2023	$ 62,247		$ 12	359,326	215	(297,306)
Beginning balance (in shares) at Mar. 31, 2023			116,729,000
Beginning balance at Mar. 31, 2023	78,111		$ 12	355,620	206	(277,727)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	3,709			3,709
Proceeds from option exercises (shares)			52,000
Proceeds from option exercises	14			14
RSUs vested (in shares)			326,000
RSUs vested	(17)			(17)
Net (loss) income	(19,579)					(19,579)
Foreign currency translation	$ 9				9
Ending balance (in shares) at Jun. 30, 2023	117,107,326		117,107,000
Ending balance at Jun. 30, 2023	$ 62,247		$ 12	$ 359,326	$ 215	$ (297,306)